4//SEC Filing
Mallon Mark 4
Accession 0001077183-22-000043
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:59 PM ET
Size
11.9 KB
Accession
0001077183-22-000043
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-03-01+142,457→ 368,051 total - Award
Stock Option (Right to Buy)
2022-03-01+347,777→ 347,777 totalExercise: $21.41Exp: 2029-03-01→ Common Stock (347,777 underlying)
Holdings
- 151,016
Stock Option (Right to Buy)
Exercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying)
Footnotes (3)
- [F1]On March 1, 2022, Mr. Mallon was granted 142,457 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 1, 2022, Mr. Mallon was granted 347,777 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001763533
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:59 PM ET
- Size
- 11.9 KB